/Join_Us.gif)
/Clinical_trial_470_x_80_(new).gif)
Clinical Trials Update provides you with latest news about clinical trials conducted by MVA member companies. The update gives insight to progress in studies, results and possible indications.
Genzyme and Isis Begin Second Phase 3 Trial of Mipomersen
6 August - Genzyme Corp. and Isis Pharmaceuticals have announced that they have begun a Phase 3 study of mipomersen in patients with heterozygous familial hypercholesterolemia, a genetic disorder that causes exceptionally high levels of LDL cholesterol. It is the first of four new trials the companies plan to initiate by the end of this year.
Genmab and GSK Announce Positive Top-Line Results in Ofatumumab Pivotal Study
31 Juli - Genmab and GlaxoSmithKline have announced positive top-line results from an interim analysis of the Phase 3 pivotal study evaluating ofatumumab to treat two groups of chronic lymphocytic leukemia patients with high unmet medical need. At the interim analysis, the study met the primary endpoint in both populations and the results from the secondary endpoints also support the primary endpoint.
